Sarcoma clinical trials
The registry lists 1,665 studies for Sarcoma across more than 10 countries. 391 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Completed
- 766
- Recruiting
- 322
- Terminated
- 183
- Active, not recruiting
- 125
- Status unknown
- 117
- Withdrawn
- 66
Phase
- Phase 2
- 749
- Phase 1
- 486
- Phase 3
- 93
- Early Phase 1
- 36
- Phase 4
- 14
Where
- United States
- 962
- France
- 171
- China
- 150
- Canada
- 140
- United Kingdom
- 108
- Italy
- 108
Who runs them
National Cancer Institute (NCI) (142) · Memorial Sloan Kettering Cancer Center (57) · M.D. Anderson Cancer Center (46) · Children's Oncology Group (38) · Institut Bergonié (23) · European Organisation for Research and Treatment of Cancer - EORTC (22) · Washington University School of Medicine (19) · Dana-Farber Cancer Institute (18)
Studies
Recruiting first, then most recently updated. Showing 50 of 1,665 — search for more.
- Utidelone Capsules Combined With Doxorubicin for Advanced Soft Tissue SarcomaNot yet recruitingNCT07842276Phase 21 country
- A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 AlterationsRecruitingNCT04094610Phase 1/211 countries
- DESTINY-PANTUMOUR04RecruitingNCT071240001 country
- A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsRecruitingNCT07229313Phase 12 countries
- Treatment of Stage IV Cancer Patients With Multiple Patient-specific Mutated Cell Surface Proteins With Chimeric AntibodiesNot yet recruitingNCT07783620Phase 1
- Anti-GD2 ADC M3554 in Advanced Solid TumorsRecruitingNCT06641908Phase 16 countries
- Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast CancerRecruitingNCT07614620Not applicable1 country
- A Study of CRD3874-SI in People With Solid TumorsRecruitingNCT06021626Phase 11 country
- A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT07705334Phase 11 country
- Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityRecruitingNCT04273061Phase 21 country
- Molecular and Clinical Studies of Bone and Soft Tissue TumorsRecruitingNCT078222041 country
- Biomarkers of Resiliency In Childhood Cancer SurgeryRecruitingNCT066748111 country
- FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory RhabdomyosarcomaRecruitingNCT06865664Phase 11 country
- First-in-Human Study of ADCE-D01 in Soft Tissue SarcomaRecruitingNCT06797999Phase 1/25 countries
- Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue TumorsRecruitingNCT07062003Not applicable1 country
- A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast CancersNot yet recruitingNCT07811232Phase 1/21 country
- A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM CancersNot yet recruitingNCT07811297Phase 1/21 country
- Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsRecruitingNCT05732831Phase 1/23 countries
- Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue SarcomaRecruitingNCT04577014Phase 1/21 country
- Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including SarcomasRecruitingNCT03715933Phase 16 countries
- A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.RecruitingNCT07734116Phase 1/21 country
- Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological StudiesRecruitingNCT011093941 country
- First-in-Human Trial of DS-2243a in Participants With Advanced Solid TumorsRecruitingNCT06644755Phase 15 countries
- Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced SarcomaRecruitingNCT05711615Phase 11 country
- The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid TumorsRecruitingNCT07459283Early Phase 11 country
- Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients.Not yet recruitingNCT07802847Phase 41 country
- GRID Therapy for Extremity Soft Tissue SarcomaRecruitingNCT06073067Not applicable1 country
- A Study to Assess Safety and Efficacy of SOT106 in Patients With LRRC15-positive Advanced Unresectable or Metastatic Osteosarcoma or Soft Tissue SarcomaNot yet recruitingNCT07801222Phase 1/21 country
- Cabozantinib With Ifosfamide in Relapsed/Refractory SarcomasRecruitingNCT06156410Phase 11 country
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)RecruitingNCT06760819Phase 211 countries
- Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and OsteosarcomaRecruitingNCT07725380Phase 1/21 country
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT053340691 country
- A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueRecruitingNCT05837767Not applicable1 country
- Serial MRI Scans During Radiation TherapyRecruitingNCT04188535Not applicable1 country
- Ovarian-Sparing Adaptive Radiotherapy in Young Adult WomenRecruitingNCT069043651 country
- Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue SarcomaRecruitingNCT04307277Phase 31 country
- A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma.RecruitingNCT07460986Phase 1/21 country
- Actinium Therapy for Late-stage Aggressive SarcomasRecruitingNCT07156565Phase 12 countries
- Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid TumorsRecruitingNCT07630961Phase 12 countries
- Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting SarcomasNot yet recruitingNCT03356782Phase 1/21 country
- Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot InterventionRecruitingNCT07662239Not applicable1 country
- Tumor-Lymph Node MappingNot yet recruitingNCT070549441 country
- Combination Immunotherapy Targeting SarcomasNot yet recruitingNCT04433221Phase 1/21 country
- STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected SarcomasRecruitingNCT06975293Phase 1/21 country
- Sarcoma and Intra-infusion Exercise for Better OutcomesNot yet recruitingNCT07785882Not applicable1 country
- Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for SarcomasRecruitingNCT05253131Phase 21 country
- Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...RecruitingNCT02390752Phase 11 country
- Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal MetastasesRecruitingNCT03965234Phase 1/21 country
- Enhanced Recovery After Surgery in Extremity SarcomaRecruitingNCT04461171Not applicable1 country
- Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy ProgramRecruitingNCT017727711 country